Significance of the assessmentTo understand the real significance of the new assessment, some background information is needed. Substances and exposures that can lead to cancer are called carcinogens. The IARC is part of the WHO, its major goal is to identify causes of cancer, and its classification for carcinogens is the most widely used and accepted in the world [3]. In the past 30 years, the IARC has evaluated the cancer-causing potential of more than 900 likely candidates, placing them into the following categories:
Evidence of glyphosate’s cancer-causing potential including that suppressed by EPAThe assessment cited the main evidence on which the classification of glyphosate as probably carcinogenic to humans is based [1] as follows: “For the herbicide glyphosate, there was limited evidence of carcinogenicity in human for non-Hodgkin lymphoma. The evidence in humans is from studies of exposures, mostly agricultural in the US, Canada, and Sweden published since 2001. In addition, there is convincing evidence that glyphosate also can cause cancer in laboratory animals. On the basis of tumours in mice, the United States Environmental Protection Agency (USEPA) originally classified glyphosate as possibly carcinogenic to humans (Group C) in 1985 [equivalent to IARC group 2C]. After a re-evaluation of that mouse study, the US EPA changes its classification to evidence to non-carcinogenicity in humans (Group E) in 1991. The US EPA Scientific Advisory Panel noted that the re-evaluated glyphosate results were still significant using two statistical tests recommended in the IARC Preamble. The IARC Working Group that conducted the evaluation considered the significant findings from the US EPA report and several more recent positive results in concluding that there is sufficient evidence of carcinogenicity in experimental animals. Glyphosate also caused DNA and chromosomal damage in human cells, although it gave negative results in tests using bacteria. One study in community residents reported increases in blood markers of chromosomal damage (micronuclei) after glyphosate formulations were sprayed nearby.” Note the pointed reference to US EPA evidence that has been suppressed. This happened through a litany of outright fraud committed by testing companies working for the corporations, deception, and half-truths (see [4] Glyphosate and Cancer, SiS 62). It should be seen in the light of EPA’s decision in 2013 to raise the allowable limits of glyphosate contamination in farm-grown food and animal feed [5]. The amount of allowable glyphosate in oilseed crops (except for canola and soy) went up from 20 ppm to 40 ppm, 100 000 times the amount needed to induce breast cancer cells. Yet more evidence was cited for animal experiments with glyphosate [2]. These included glyphosate induced positive trend in the incidence of a rare renal tubule carcinoma in male CD-1 mice, a positive trend for haemangiosarcoma in male mice, pancreatic islet-cell adenoma in male rats in two studies, and a promotion of skin tumours in an initiation-promotion study in mice [6]. Also pointed out in the assessment [2], glyphosate has been detected in the blood and urine of agricultural workers, indicating absorption into the body. Soil microbes are known to degrade glyphosate to aminomethylphosphoric acid (AMPA). Blood AMPA detection after poisonings therefore suggests intestinal microbial metabolism in humans. Glyphosate and glyphosate formulations induced DNA and chromosomal damage in mammals, and in human and animal cells in vitro. One study reported increases in blood markers of chromosomal damage (micronuclei) in residents of several communities after spraying of glyphosate formulations. Bacterial mutagenesis tests were negative, but glyphosate, glyphosate formulations, and AMPA induced oxidative stress in rodents and in vitro. Oxidative stress induces reactive oxygen species that can damage DNA [7]. Since our last review on glyphosate and cancer [4], new evidence has emerged. Leah Schinasi and Maria Leon at IARC, Lyon, France carried out a systematic review and a series of meta-analyses of nearly three decades worth of epidemiologic research on the relationship between non-Hodgkin lymphoma (NHL) and occupational exposure to agricultural pesticide active ingredients and chemical groups. Estimates of associations of NHL with 21 pesticides and 80 active ingredients were extracted from 44 papers, all reporting studies conducted in high-income countries (12 countries, majority in Europe or N. America) [8]. Random effects meta-analyses (allowing heterogeneity between studies to contribute to the variance) showed that phenoxyherbicides, carbamate insectices, organophosphorus insecticide and the active ingredient lindane, an organochlorine insecticide, were positively associated with NHL. In addition, in a handful of papers, associations between pesticides and NHL subtypes were reported: B cell lymphoma was positively associated with phenoxy herbicides and glyphosate. Diffuse large B-cell lymphoma was positively associated with phenoxy herbicide exposure. New evidence has also come from Argentina, where a team of researchers at Universidad Nacional de Rio Cuarto used a recently established method for monitoring genetic damage resulting from chemical exposure by determining the frequency of micronuclei in the cells lining the inside of the mouth [9]. They found that children living within 500 m of spraying areas have over 66 % more cells with micronuclei than those living more than 3 000 m away. In addition, 40 % of the exposed children suffer from persistent conditions that may be associated with chronic pesticide exposure including respiratory symptoms, with and without additional symptoms such skin itching or stains, nose itching or bleeding, lacrimation, eye and ear burning or itching.Monsanto, the Glyphosate Task Force, and the Joint Glyphosate Task Force protest against classificationMonsanto, whose $15.9 billion of annual sales are closely tied to glyphosate [10], protested that the scientific data did not support the conclusions and called on WHO to hold an urgent meeting to explain the findings [11]. “We don’t know how IARC could reach a conclusion that is such a dramatic departure from the conclusion reached by all regulatory agencies around the globe,” Philip Miller, Monsanto’s vice-president of global regulatory affairs, told the press. Apart from the EPA’s 2013 hike of allowable glyphosate contamination levels [5], the German government completed a four year evaluation of glyphosate for the EU, concluding that it was “unlikely to pose a carcinogenic risk in humans” [12]. The Glyphosate Task Force (GTF) is a consortium of chemical companies, including Monsanto, formed to promote glyphosate in Europe. The Joint Glyphosate Task Force (JGTF) is the US counterpart. On the same day that the Lancet article [2] was published, both the GTF and the JGTF published announcements decrying the WHO classification [13]. They accuse the IARC of only taking into account “a narrow selection of studies and was therefore made without the benefit of analyzing the extensive and relevant database on glyphosate relied upon by the world's regulatory authorities...” They then lauded the German glyphosate re-assessment report (RAR) saying, “As recently as January, the German government completed a four-year study of glyphosate on behalf of the European Union and concluded that glyphosate was unlikely to pose a carcinogenic risk in humans. It is baffling that IARC arrived at such a different conclusion than all these other scientific reviews.” Of course they would refer to the RAR. They wrote it. The GTF prepared the dossier on glyphosate renewal for the German member state and submitted it to the Federal Institute for Risk Assessment (BfR) in Germany. The BfR rubber-stamped it and sent it on to the European Food Safety Authority (EFSA), adding only a few comments here and there. Finally, the GTF accuses the IARC of not taking into account all of the data available, particularly the industry-sponsored studies [14]. “Most peer reviewed literature and other publicly available information such as the evaluations, opinions and conclusions of regulatory competent authorities were also dismissed by IARC.”Corrupt assessment in the European UnionIt is supreme irony for GTF to accuse IARC of not taking into account all of the data available, as the GTF’s assessment on behalf of the German government was most narrowly based on industry studies and others that concurred with the findings from industry. In the carcinogenicity section of toxicology portion of the RAR, 13 industry-sponsored studies were evaluated. All were deemed “acceptable” and all found no significant carcinogenetic effects. Two published studies on rodents were considered. One found no significant results and the other was “considered by the authors to indicate a tumor promoting potential of glyphosate. However, the formulation Roundup was used in the study and not the active substance glyphosate.” All studies that used an actual product were disqualified because they claim that only the active ingredient, glyphosate, needs to be evaluated [15]. Twelve peer-reviewed studies, most of which were based on data from a single study (the Agricultural Health Study), found no evidence of carcinogenicity. These studies were all deemed reliable and used in the evaluation. Only six studies finding a link between glyphosate and cancer were included in the RAR but were disqualified and deemed unreliable, mostly because exact exposures to glyphosate could not be identified in the epidemiological studies. The one lab study (Seralini) was disqualified because they didn't follow OECD guidelines. And this was only the cancer section. For more details see [15] Scandal of Glyphosate Re-assessment in Europe, SiS 63 and [17].Glyphosate bans already under considerationFortunately, there are non-corrupt regulatory agencies in the world that look at the whole range of evidence on glyphosate toxicity, of which being a probable human carcinogen is just one aspect (see [18] A Roundup of Roundup® Reveals Converging Pattern of Toxicity from Farm to Clinic to Laboratory Studies, SiS 65). Glyphosate and in particular the Monsanto formulations Roundup is a wide-spectrum weed killer with wide-spectrum toxicities on organisms and cells. A number of countries have already imposed bans on the herbicide. Sri Lanka had originally imposed a total ban based on evidence of glyphosate link to a deadly kidney disease, with prevalence estimated at 15 % affecting a total of 400 000 patients with an estimated death toll of around 20 000. Under pressure from industry, it has now a partial ban in certain districts [19]. El Salvador, stricken with the same lethal kidney disease epidemic, has voted to ban glyphosate along with 52 other chemicals since 2013 [20], though it has yet to be written into law, again under great pressure from industry. Brazil’s Federal Public Prosecutor has requested the Justice Department to ban glyphosate along with 8 other chemicals [21]. Finally, the Dutch Parliament voted for a ban on non-agricultural uses [22].To concludeIndividuals, farmers, gardeners, restaurants, shops, local communities should now stop using glyphosate herbicides in defiance of the corrupt approvals given, in order to safeguard the health of people and planet.References
O
|